Bionano Genomics (BNGO) Cost of Revenue (2017 - 2026)
Bionano Genomics (BNGO) posted Cost of Revenue of $3.4 million for Q1 2026, down 24.54% sequentially from $4.6 million in Q4 2025, and down 2.39% YoY from $3.5 million in Q1 2025.
Bionano Genomics (BNGO) Cost of Revenue (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Cost of Revenue for 10 years, with the latest figure at $3.4 million in Q1 2026.
- Quarterly Cost of Revenue fell 2.39% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.2 million (down 34.82% YoY) and the FY2025 annual result came in at $15.3 million, down 49.59% from the prior year.
- Cost of Revenue retreated to $3.4 million in Q1 2026 per BNGO's latest filing, from $4.6 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $14.5 million in Q3 2024 and troughed at $157000.0 in Q4 2024.
- A 5-year average of $5.5 million and a median of $5.2 million in 2022 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue sank 98.1% in 2024, then surged 2799.36% in 2025.
- Over 5 years, Cost of Revenue stood at $6.4 million in 2022, then increased by 29.22% to $8.3 million in 2023, then tumbled by 98.1% to $157000.0 in 2024, then soared by 2799.36% to $4.6 million in 2025, then dropped by 24.54% to $3.4 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $3.4 million, $4.6 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 2.67 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 1.13 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 602.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.47 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 807.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 1.93 Bn |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Mn |
| Jun 30, 2026 | 3.86 Mn |
| Mar 31, 2026 | 3.44 Mn |
| Mar 31, 2026 | 3.44 Mn |
| Dec 31, 2025 | 4.55 Mn |
| Dec 31, 2025 | 4.55 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 157,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | 14.52 Mn |
| Sep 30, 2024 | 14.52 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 5.95 Mn |
| Mar 31, 2024 | 5.95 Mn |